{"resourceType":"ValueSet","id":"2.16.840.1.113762.1.4.1116.599","meta":{"versionId":"5","lastUpdated":"2020-02-04T01:00:20.000-05:00"},"text":{"status":"generated","div":"<div xmlns=\"http://www.w3.org/1999/xhtml\">\n      <h2>Obinutuzumab</h2>\n      <p>This value set includes codes from the following code systems:</p>\n      <ul>\n        <li>Include these codes as defined in \n          <a href=\"http://www.nlm.nih.gov/research/umls/rxnorm\">\n            <code>http://www.nlm.nih.gov/research/umls/rxnorm</code>\n          </a>\n          <table class=\"none\">\n            <tr>\n              <td>\n                <b>Code</b>\n              </td>\n              <td>\n                <b>Display</b>\n              </td>\n            </tr>\n            <tr>\n              <td>1442690</td>\n              <td>obinutuzumab 25 MG/ML</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>1442691</td>\n              <td>obinutuzumab Injectable Product</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>1442695</td>\n              <td>obinutuzumab 25 MG/ML [Gazyva]</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>974779</td>\n              <td>obinutuzumab</td>\n              <td/>\n            </tr>\n          </table>\n        </li>\n      </ul>\n    </div>"},"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.599","version":"20200204","name":"Obinutuzumab","status":"active","date":"2020-02-04T01:00:20-05:00","publisher":"American Society of Clinical Oncology Steward","compose":{"include":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","concept":[{"code":"1442690","display":"obinutuzumab 25 MG/ML"},{"code":"1442691","display":"obinutuzumab Injectable Product"},{"code":"1442695","display":"obinutuzumab 25 MG/ML [Gazyva]"},{"code":"974779","display":"obinutuzumab"}]}]}}